Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2008-07-29
2008-07-29
Davis, Zinna N. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S252130, C514S300000, C544S111000, C544S362000, C546S113000
Reexamination Certificate
active
10851902
ABSTRACT:
Compounds represented by Formula (I):or pharmaceutically acceptable salts thereof, are inhibitors of glycogen phosphorylase and are useful in the prophylactic or therapeutic treatment of diabetes, hyperglycemia, hypercholesterolemia, hyperinsulinemia, hyperlipidemia, hypertension, atherosclerosis or tissue ischemia e.g. myocardial ischemia, and as cardioprotectants.
REFERENCES:
patent: 4931429 (1990-06-01), Hanson et al.
patent: 5346907 (1994-09-01), Kerwin, Jr. et al.
patent: 5618792 (1997-04-01), Gyorkos et al.
patent: 5618825 (1997-04-01), Baldwin et al.
patent: 5672582 (1997-09-01), Veber et al.
patent: 5710153 (1998-01-01), Ohmoto et al.
patent: 5756810 (1998-05-01), Baldwin et al.
patent: 5821241 (1998-10-01), Claremon et al.
patent: 5869455 (1999-02-01), Gyorkos et al.
patent: 5885967 (1999-03-01), Schacht et al.
patent: 5952322 (1999-09-01), Hoover et al.
patent: 6001811 (1999-12-01), Gyorkos et al.
patent: 6034067 (2000-03-01), Grootenhuis et al.
patent: 6037325 (2000-03-01), Gyorkos et al.
patent: 6090787 (2000-07-01), Schacht et al.
patent: 6107309 (2000-08-01), Bhatnagar et al.
patent: 6107329 (2000-08-01), Hoover et al.
patent: 6124277 (2000-09-01), Schacht et al.
patent: 6150387 (2000-11-01), Bohme et al.
patent: 6174887 (2001-01-01), Haruta et al.
patent: 6277877 (2001-08-01), Hoover et al.
patent: 6297269 (2001-10-01), Hulin et al.
patent: 6399601 (2002-06-01), Du Bois
patent: 6410684 (2002-06-01), Adang
patent: 6420561 (2002-07-01), Haruta et al.
patent: 6432921 (2002-08-01), Adang et al.
patent: 6455529 (2002-09-01), Gante et al.
patent: 2003/0004162 (2003-01-01), Treadway
patent: 0254545 (1988-01-01), None
patent: 0 321 192 (1989-06-01), None
patent: 0345990 (1989-12-01), None
patent: 0 712 844 (1996-05-01), None
patent: 0810221 (1997-12-01), None
patent: 0 846 464 (1998-06-01), None
patent: 0846464 (1998-06-01), None
patent: 1101759 (2001-05-01), None
patent: 0832066 (2001-09-01), None
patent: 1136071 (2001-09-01), None
patent: 0832065 (2001-10-01), None
patent: 1179341 (2002-02-01), None
patent: 1201239 (2002-05-01), None
patent: 0978276 (2002-09-01), None
patent: 2292149 (1996-02-01), None
patent: WO96/36595 (1996-11-01), None
patent: WO96/39384 (1996-12-01), None
patent: WO97/17985 (1997-05-01), None
patent: WO97/28798 (1997-08-01), None
patent: WO97/31016 (1997-08-01), None
patent: WO98/25617 (1998-06-01), None
patent: WO 00/43384 (2000-07-01), None
patent: WO 00/44753 (2000-08-01), None
patent: WO 00/69815 (2000-11-01), None
patent: WO 00/76970 (2000-12-01), None
patent: WO 01/02424 (2001-01-01), None
patent: WO 01/32622 (2001-05-01), None
patent: WO 01/55146 (2001-08-01), None
patent: WO 01/62775 (2001-08-01), None
patent: WO 01/68055 (2001-09-01), None
patent: WO 01/94310 (2001-12-01), None
patent: WO 01/96346 (2001-12-01), None
patent: WO 02/16314 (2002-02-01), None
patent: WO 02/20475 (2002-03-01), None
patent: WO 02/20530 (2002-03-01), None
patent: WO 02/26697 (2002-04-01), None
patent: WO 02/40469 (2002-05-01), None
patent: WO 02/46159 (2002-06-01), None
patent: WO03042178 (2002-11-01), None
patent: WO 03/064423 (2003-08-01), None
patent: WO 2004/039807 (2004-05-01), None
Benjamin Frydman, Santiago J. Reil, Juan Boned, & Henry Rapoport, Synthesis of Substituted 4- and 6-Azaindoles, J. Org. Chem. 33:10 3762-3766 (1968).
George A. Patani & Edmond J. LaVoie, Bioisosterism: A Rational Approach in Drug Design, Chem. Rev. 96:3147-3176 (1996).
Ross et al.,American Journal of Physiology. Heart and Circulatory Physiology, Mar. 2004, 286(3), H1177-84.
R. Kurukulasuriya, J.T. Link, et al.,Current Medicinal Chem., 10:99-121(2003).
R. Kurukulasuriya, J.T. Link, et al.,Current Medicinal Chem., 10:123-153(2003).
S.P. Hiremath et al.,Acta Ciencia Indica, XVIII:397(1992).
Kermack, et al.,J. Chem, Soc., 1921, 119, 1602.
Cannon et al.,J. Med. Chem., 1981, 24, 238.
Chen et al, J. Org. Chem. 1997, 62, 2676.
Sy, W.,Synth. Commun., 1992, 22, 3215.
Spivey et al.,J. Org. Chem., 1999, 64, 9430.
Hands et al.,Synthesis, 1996, 7, 877.
A. Fässler et al., (Tetrahedron Lett., 1998, 39, 4925.
Johnson et.al.,J. Med. Chem., 1986, 29, 2100-2104.
Wermuth, et al. “The Practise of Medicinal Chemistry” Practice of Medicinal Chemistry 1996 pp. 203-237 Chapter IIC and IID.
Bradley Stuart Edward
Krulle Thomas Martin
Murray Peter John
Procter Martin James
Rowley Robert John
Davis Zinna N.
Forman Frank
OSI Pharmaceuticals, Inc.
Rafa Michael
Stewart Lex
LandOfFree
Pyrrolopyridine-2-carboxylic acid amide inhibitors of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrrolopyridine-2-carboxylic acid amide inhibitors of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrrolopyridine-2-carboxylic acid amide inhibitors of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3954936